Tesla Faces NHTSA Probe, Dutch FSD Decision Looms

Introduction

Last week brought concrete developments that directly affect Tesla (TSLA): a U.S. safety agency moved its investigation of Tesla’s Full Self-Driving (FSD) system into a more advanced engineering phase, and European regulators are nearing a decision that could either relieve or amplify regulatory risk. At the same time, scrutiny of Tesla’s valuation intensified even as the company rolled out incremental product updates. These events—regulatory actions, investor critique, and product news—have immediate implications for TSLA shares and investor expectations.

Regulatory Pressure: NHTSA Escalates FSD Probe

On March 18, the U.S. National Highway Traffic Safety Administration (NHTSA) elevated its inquiry into Tesla’s FSD software to an engineering analysis, the step that precedes a possible safety recall. That probe covers roughly 3.2 million vehicles across Tesla’s lineup, including Model 3, Model Y, Model S, Model X and Cybertruck. The market reacted quickly: TSLA shares fell about 3.2% on March 20, closing near $380—reflecting investor concern that regulatory scrutiny could delay or limit commercialization of Tesla’s autonomy roadmap.

Why this matters for TSLA

Autonomy is a cornerstone of Tesla’s long-term growth narrative and valuation. An advanced regulatory review raises the prospect of mandated software changes, operational restrictions, or even recalls that would slow rollout timelines and add costs. Think of it as a final safety inspection on a new product line—if the inspector finds systemic flaws, distribution can be halted until those flaws are fixed, hurting near-term revenue and investor confidence.

European Watch: Dutch Decision Could Set Tone

Tesla is also awaiting a decision from Dutch regulator RDW, expected by April 10, on a supervised version of its FSD offering. Approval in the Netherlands would be a meaningful regulatory milestone in Europe and could pave the way for broader acceptance across EU jurisdictions. Conversely, a rejection or additional conditions would underscore the uneven global regulatory environment for automated-driving software.

Investor implications

A positive Dutch ruling would act as a tangible catalyst—softening some regulatory concerns and reinforcing the software-revenue story. Failure to secure approval would extend uncertainty and keep a regulatory overhang on TSLA shares.

Valuation Scrutiny and Market Share Signals

Alongside regulatory headlines, investor analysts flagged Tesla’s stretched valuation. One note highlighted a forward-price-to-earnings multiple near 376× and a notional $1.5 trillion market cap—figures that assume flawless execution across unproven businesses such as robotaxis, energy services, and robotics. The critique also pointed to decelerating share gains: U.S. EV share has reportedly fallen from about 79% in 2020 to roughly 46% in 2025, European share near 9%, and notable declines in Chinese sales in early 2026.

Takeaway

These observations reframe Tesla’s risk profile: the upside drivers are still largely forward-looking and dependent on regulatory approvals and execution across new verticals. For investors, that elevates the importance of near-term proof points—delivery execution, regulatory clearances, and concrete revenue from non-vehicle businesses.

Product Updates: Semi Redesign and Roadster Timing

Amid the scrutiny, Tesla unveiled an updated Semi with lighter weight and sleeker aerodynamics—changes that improve efficiency and commercial viability. Separately, filings and executive comments confirm a next-generation Roadster unveiling is expected by the end of April. While these moves do not resolve regulatory questions around FSD, they demonstrate continued engineering progress and the company’s ability to iterate on hardware.

Context for investors

Product improvements, like the Semi’s weight reduction, are tangible execution wins that can bolster revenue in adjacencies such as commercial transport. The Roadster is mostly a halo product but signals design and manufacturing capabilities that keep the brand momentum alive.

Conclusion

Last week’s developments placed regulatory outcomes and valuation realism at center stage for TSLA. The NHTSA’s escalation increases headline risk and could delay key autonomy milestones, while the Dutch decision expected by April 10 is a discrete near-term catalyst that could either relieve or amplify that pressure. Meanwhile, valuation critiques underscore the need for clearer revenue proof points outside the core vehicle business. Product updates—Semi redesign and Roadster timing—offer execution positives but are unlikely to offset regulatory or valuation concerns on their own. Investors should monitor the NHTSA review, the RDW decision, and upcoming delivery and revenue disclosures as the primary, non-speculative factors likely to move TSLA shares in the short term.